Download

Full Document

FormatFile SizeNotes
zip file 0.2 MB

The file(s) provided above are ZIP-formatted archives, which most modern systems can natively unpack. If your computer does not unpack the archive when you double-click it, you may need to use a separate decompression program such as UnZip.

Purchase

Purchase Print Copy

 FormatList Price Price
Add to Cart Paperback49 pages $10.00 $8.00 20% Web Discount

This report synthesizes the findings of a review of the structure and performance of the Safe and Drug-Free Schools and Communities Act (SDFSCA) and assesses options for reforming it. The Act provides for a $600-million-per-year program of grants to states, which pass the money onto school districts for programs aimed at reducing school violence and drug abuse. However, the formula by which money is disbursed does not focus on the schools most in need of help, and it spreads the money too thinly. Moreover, the guidelines for expenditure permit schools to use the funds for programs that are unproven, and the legislation gives the federal government limited ability to foster effective programs. The SDFSCA program has not been credibly evaluated, but it is widely thought to have accomplished little. Yet the problems it addresses are so serious and widespread that the federal government cannot reasonably afford to abandon its commitment. Few proposals for reform have been offered, and only the one put forth by the Clinton administration is currently fully developed. That proposal moves in the right direction, but it addresses only some of the ways in which the program could be improved. This report suggests criteria for judging reform options and presents ways in which the proposal under discussion could be strengthened.

Table of Contents

  • Preface

  • Summary

  • Chapter One

    Introduction

  • Chapter Two

    Assessment

  • Chapter Three

    Changing the Program

  • Chapter Four

    Conclusions and Recommendations

  • References

The research described in this report wasperformed under the auspices of RAND's Drug Policy Research Center.

This report is part of the RAND Corporation monograph report series. The monograph/report was a product of the RAND Corporation from 1993 to 2003. RAND monograph/reports presented major research findings that addressed the challenges facing the public and private sectors. They included executive summaries, technical documentation, and synthesis pieces.

Permission is given to duplicate this electronic document for personal use only, as long as it is unaltered and complete. Copies may not be duplicated for commercial purposes. Unauthorized posting of RAND PDFs to a non-RAND Web site is prohibited. RAND PDFs are protected under copyright law. For information on reprint and linking permissions, please visit the RAND Permissions page.

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.